AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 31 min read$ATR

Vinczeller Shiela sold $100K of ATR

Vinczeller Shiela (Chief Human Resources Officer) sold 765 shares of APTARGROUP, INC. (ATR) at $130.37 on 2026-09-02.

Original reporting
SEC EDGAR · Vinczeller Shiela
Published Sep 3, 2026, 4:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 3, 2026, 4:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ATR
Bearish
medium confidence
Mentioned
$ATR
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATRBearishLow
01

Why it matters

Provides fresh primary data on insider activity.

02

Market read

Insider sale of ~0.3% of holdings may slightly affect ATR's stock perception.

03

What to watch

Sale represents less than 1% of total holdings.

Relevance 3/10Novelty 4/10Timing: filing today

Background

Form 4 filing discloses insider transactions required by SEC.

Company-level read

Ticker impact

$ATRBearishMedium confidence
Context

Chief Human Resources Officer sold 765 shares for $99,732, indicating insider selling pressure.

Expected impact

Modest price dip expected in near term.

Evidence & confidence

Sale size is modest relative to holdings but signals possible concerns.

Market effects

Sector

Minimal impact on biotech sector.

Regional

None.

Global

Low.

Counterpoint

What could challenge this read

Insider sale may be routine portfolio rebalancing, not a red flag.

Key entities

  • Company
    Aptargroup, Inc.

    Biotech firm listed on NYSE under ticker ATR.

  • Person
    Vinczeller Shiela

    Chief Human Resources Officer of Aptargroup.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ATR insider trading history →

Related articles

AUG 11
$ATRMed

Publication of a Circular

Schroder Asian Total Return Investment Company plc (ATR) said it has published a circular for shareholders on a proposed combination with Pacific Assets Trust plc (PAC). The plan would use a scheme of reconstruction and PAC’s members’ voluntary winding-up, transferring most PAC assets and issuing New ATR shares. A cash option is capped at 25% with a 2% discount; shareholder approval is required.

investegate.co.uk6 min
AUG 8
$ATRMedAI 8/10

Aptar (ATR) Q2 2026 Earnings Call Transcript

AptarGroup (ATR) reported Q2 2026 total sales of $1.03B, up 6% reported, with adjusted EPS of $1.42 above guidance. Adjusted EBITDA was $213M, down 3%, and margins fell due to mix and operational issues in beauty. Pharma core sales grew 8% excluding emergency medicine destocking. Net debt was $1.2B, leverage 1.49x, and Q3 adjusted EPS guidance is $1.45 to $1.53.

fool.com6 min
JUL 30
$ATRMed

APTARGROUP, INC. (ATR): Results of Operations and Financial Condition

APTARGROUP, INC. (ATR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Aptar Reports Second Quarter 2026 Results Crystal Lake, Illinois, July 30, 2026 -- AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today reported the following second quarter results

SEC EDGAR 8-K6 min